RAPT Therapeutics Inc RAPT:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 2:33 PM EDT
4.12quote price arrow up+0.12 (+3.03%)
Volume
588,792
52 week range
3.98 - 27.35
Loading...
  • Open4.10
  • Day High4.23
  • Day Low4.05
  • Prev Close4.00
  • 52 Week High27.35
  • 52 Week High Date02/12/24
  • 52 Week Low3.98
  • 52 Week Low Date05/14/24

Key Stats

  • Market Cap143.417M
  • Shares Out34.80M
  • 10 Day Average Volume1.33M
  • Dividend-
  • Dividend Yield-
  • Beta0.28
  • YTD % Change-83.42

KEY STATS

  • Open4.10
  • Day High4.23
  • Day Low4.05
  • Prev Close4.00
  • 52 Week High27.35
  • 52 Week High Date02/12/24
  • 52 Week Low3.98
  • 52 Week Low Date05/14/24
  • Market Cap143.417M
  • Shares Out34.80M
  • 10 Day Average Volume1.33M
  • Dividend-
  • Dividend Yield-
  • Beta0.28
  • YTD % Change-83.42

RATIOS/PROFITABILITY

  • EPS (TTM)-3.07
  • P/E (TTM)-1.34
  • Fwd P/E (NTM)-1.52
  • EBITDA (TTM)-126.756M
  • ROE (TTM)-67.21%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-10,456.09%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/09/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On RAPT Therapeutics Inc

 

Profile

MORE
RAPT Therapeutics, Inc. is a clinical-stage immunology-based biopharmaceutical company. The Company is focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in inflammatory diseases and oncology. Utilizing its drug discovery and development engine, it develops selective small molecules designed to modulate the critical immune responses underlying these diseases. Its lead inflammation drug candidate...
William Rieflin
Independent Chairman of the Board
Brian Wong M.D., Ph.D
President, Chief Executive Officer, Director
Rodney Young
Chief Financial Officer
Address
561 Eccles Ave
South San Francisco, CA
94080-1906
United States

Top Peers

SYMBOLLASTCHG%CHG
RANI
Rani Therapeutics Holdings Inc
5.49-0.29-5.02%
CRDF
Cardiff Oncology Inc
3.56-0.02-0.56%
RGLS
Regulus Therapeutics Inc
2.04-0.04-1.92%
ACHV
Achieve Life Sciences Inc
5.33+0.32+6.39%
CNTX
Context Therapeutics Inc
1.71UNCHUNCH